8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
Published . Updated .
8-K - GYRE THERAPEUTICS filed an 8-K with the SEC on Oct 22 (a notice of a material company event).
Directly affected
- GYRE Gyre Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500+1.6%
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond-1.8%
Long-term U.S. government bonds
- QQQ Invesco QQQ+2.3%
Large technology stocks
- GLD SPDR Gold Shares-3.3%
Gold can move with the broad market
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| GYRE | +4.02% | +5.56% | base | after close | after close | after close | after close |
| SPY | -0.09% | +0.66% | base | after close | after close | after close | after close |
| TLT | -2.07% | -1.97% | base | after close | after close | after close | after close |
| QQQ | +0.75% | +1.80% | base | after close | after close | after close | after close |
| GLD | +3.51% | +2.33% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-22 AccNo: 0001140361-26-040506 Size: 416 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial St…
Source: sec-edgar
The price since 22 Oct 2026: Gyre Therapeutics (GYRE) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| GLD | three days earlier | +2.33% | final price |
| GLD | five days earlier | +3.51% | final price |
| Gyre Therapeutics (GYRE) | three days earlier | +5.56% | final price |
| Gyre Therapeutics (GYRE) | five days earlier | +4.02% | final price |
| QQQ | three days earlier | +1.80% | final price |
| QQQ | five days earlier | +0.75% | final price |
| SPY | three days earlier | +0.66% | final price |
| SPY | five days earlier | -0.09% | final price |
| TLT | three days earlier | -1.97% | final price |
| TLT | five days earlier | -2.07% | final price |
Who gains and who loses around Gyre Therapeutics (GYRE)
Companies carried with this story
- GYRE Gyre Therapeutics
In “8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer),” Gyre Therapeutics (GYRE) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> GYRE
How “8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)” reaches Gyre Therapeutics (GYRE)
The 22 Oct 2026 story “8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)” names Gyre Therapeutics (GYRE) because of this story.
For Gyre Therapeutics (GYRE), the reason on file says SEC 8-K filing -> direct issuer disclosure -> GYRE
How solid “8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)” looks
14 out of 100
“8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.